| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |